Back to Research

Organization profile

Maximon

Maximon is a Swiss-based longevity company builder that operationally co-founds and finances science-based startups focused on healthy aging and rejuvenation. By bridging the gap between scientific research and entrepreneurial execution, Maximon builds a diverse portfolio of companies across the longevity value chain, from supplements and personalized diagnostics to senior co-living solutions.

Zug, SwitzerlandFounded 2021

Overview

1. Executive Summary (Confidence: High)

Maximon is a pioneer in the longevity sector, operating as a company builder that identifies promising business opportunities and builds impactful, scalable ventures from scratch. Founded by a team of globally successful entrepreneurs—including Tobias Reichmuth and Marc P. Bernegger—the firm provides proven structures, financing, and a unique playground for entrepreneurs. Since its inception, Maximon has helped build several notable companies, including Avea (longevity supplements), Biolytica (health analytics), and LIV Lounge (personalized clinics), with Avea already reporting performance 50% above business plan. With a CHF 100 million Co-Investment Fund and a rigorous "venture building process," Maximon is strategically positioned to capitalize on longevity as a disruption to every major industry.

Unlock the full profileGet the complete company dossier

This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.

Desktop only

Research is currently available on desktop only.

The Research module is designed for larger screens. Please reopen it on a desktop or laptop to use the screener, filters, detail pages, and admin tools.